Although we fail to detect the direct association between RNF168 and ERɑ, RNF168, which is detected at the ERɑ promoter region, offers a potential mechanism that RNF168 modulates ERɑ signalling via controlling its transcription in breast cancers. Here, ESR1 is linked to breast carcinoma.